Literature DB >> 11266523

Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases.

K A Downes1, J R Goldblum, E A Montgomery, C Fisher.   

Abstract

Pleomorphic liposarcoma is a variant of liposarcoma defined morphologically by the presence of pleomorphic lipoblasts. Because of its rarity, there are limited studies with long-term follow-up information. Nineteen pleomorphic liposarcomas were studied. Unequivocal pleomorphic lipoblasts were required for inclusion. In each case, the following features were noted: tumor site; tumor size; tumor depth; predominant histologic pattern (epithelioid or malignant fibrous histiocytoma [MFH]-like); extent of necrosis (absent, less than 15%, or at least 15%); mitotic counts; treatment and clinical follow-up. Patients were 11 females and 8 males, aged 33-87 years (mean, 64.5 y; median, 70 y). Tumors involved the extremities (13 patients: intramuscular in 10, subcutaneous in 2, depth unknown in 1), retroperitoneum (4 patients), mediastinum (1 patient), and paratesticular region (1 patient). Size ranged from 4.5--31 cm (mean, 11.9 cm; median, 12.0 cm). Predominant pattern was epithelioid in 7 and MFH-like in 12. Necrosis was present in 15 (79%) and was extensive (36 15%) in 14 patients. Mitotic counts ranged from 0.2--3.4/10 high-power fields (mean, 1.4; median, 1.4) by the average-count method and from 1--6/10 high power fields by the highest count method (mean, 2.9; median, 3.0). All patients were treated surgically; 10 patients received adjuvant chemotherapy and/or radiation therapy. On follow-up of 18 patients (range, 2--129 mo; mean, 35.4 mo; median, 23 mo) nine (50%) were dead of disease (range, 2--48 mo; mean, 20.1 mo; median, 12 mo), one died of other causes 2 months after diagnosis, two were alive with disease, five were disease free, and one was alive at 129 months (tumor status unknown). Five had recurrences (range, 3--28 mo; mean, 14.4 mo; median, 8 mo), and four of five (80%) with recurrences were dead of disease. Metastases developed in eight patients (range, 4--48 mo; mean, 19.5 mo; median, 11.5 mo), most commonly to the lungs. In conclusion, pleomorphic liposarcoma is a rare tumor of adulthood that occurs most commonly in the deep, soft tissues of the extremities. It behaves as a high-grade sarcoma that frequently metastasizes, most commonly to the lungs. Although this tumor has a wide range of histologic appearances, no clinical or pathologic feature is predictive of a more aggressive clinical course.

Entities:  

Mesh:

Year:  2001        PMID: 11266523     DOI: 10.1038/modpathol.3880280

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  27 in total

Review 1.  [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].

Authors:  G Mechtersheimer; M Renner; R Penzel; P Schirmacher
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

2.  Successful resection of a massive mediastinal liposarcoma that rapidly extended into the entire left thoracic cavity: report of a case.

Authors:  Yasuaki Kashu; Shungo Yukumi; Nobuo Tsunooka; Kazufumi Tanigawa; Motoki Arakane; Hiromichi Nakagawa; Kanji Kawachi
Journal:  Surg Today       Date:  2011-11-03       Impact factor: 2.549

3.  Wartime toxin exposure: recognising the silent killer.

Authors:  Kamran Khan; Susan E Wozniak; JoAnn Coleman; Mukund S Didolkar
Journal:  BMJ Case Rep       Date:  2016-12-01

4.  Pleomorphic liposarcoma: clinical observations and molecular variables.

Authors:  Markus P Ghadimi; Ping Liu; Tingsheng Peng; Svetlana Bolshakov; Eric D Young; Keila E Torres; Chiara Colombo; Aviad Hoffman; Dominique Broccoli; Jason L Hornick; Alexander J Lazar; Peter Pisters; Raphael E Pollock; Dina Lev
Journal:  Cancer       Date:  2011-05-19       Impact factor: 6.860

5.  Radiological-pathological correlation of pleomorphic liposarcoma of the anterior mediastinum in a 17-year-old girl.

Authors:  Maysa Saeed; Sara Plett; Grace E Kim; H Daldrup-Link; J Courtier
Journal:  Pediatr Radiol       Date:  2010-09-09

6.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

7.  Paratesticular sarcomas: our case series.

Authors:  Ülkü Küçük; Ümit Bayol; Emel Ebru Pala; Özlem Akman; Rauf Taner Divrik
Journal:  Turk J Urol       Date:  2013-06

Review 8.  Myofibrosarcoma.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2004-06-02       Impact factor: 4.064

9.  Liposarcoma of the colon presenting as an endoluminal mass.

Authors:  Marco D'Annibale; Maurizio Cosimelli; Renato Covello; Elisa Stasi
Journal:  World J Surg Oncol       Date:  2009-10-23       Impact factor: 2.754

10.  Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.

Authors:  Ralf J Rieker; Juergen Weitz; Burkhard Lehner; Gerlinde Egerer; Andrea Mueller; Bernd Kasper; Peter Schirmacher; Stefan Joos; Gunhild Mechtersheimer
Journal:  Virchows Arch       Date:  2009-12-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.